NM_002609.4:c.2549A>T
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PM2PP3_StrongPP5_Moderate
The NM_002609.4(PDGFRB):c.2549A>T(p.Asp850Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_002609.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PDGFRB | NM_002609.4 | c.2549A>T | p.Asp850Val | missense_variant | Exon 18 of 23 | ENST00000261799.9 | NP_002600.1 | |
PDGFRB | NM_001355016.2 | c.2357A>T | p.Asp786Val | missense_variant | Exon 17 of 22 | NP_001341945.1 | ||
PDGFRB | NM_001355017.2 | c.2066A>T | p.Asp689Val | missense_variant | Exon 18 of 23 | NP_001341946.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Infantile myofibromatosis Pathogenic:1
This somatic mutation was found in two patients with myofibromatosis. It strongly activates PDGFRB signaling in cell culture (gain of function). It is homologous to pathogenic mutations in receptors of the same family, such as PDGFRA D842V and KIT D816V (in gastrointestinal stromal tumors). We sequenced PDGFRB in myofibromatosis cases using the Ion Torrent technology. All variants were confirmed by an alternative method (allele specific PCR or Sanger sequencing). Mutants were functionally characterized in experiments based on cell transfection. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at